Draft guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Slides referencing similar topics
Risk Management System (EU-RMP) GUIDELINE ON RISK MANAGEMENT SYSTEMS FOR MEDICINAL PRODUCTS FOR HUMAN USE
Michael Hellwig • Oct 27, 2017
The Harmonized PAT Solution: Application of Risk-Based Tools & PAT Strategies in Pharmaceutical Product Manufacture
Jeffrey A. Priem • Oct 27, 2017
Evaluation of Mixture Exposures in Human Health Risk Assessments
Ruth Custance • Apr 21, 2018